Positron Emission Tomography Using [18F]Fluorodeoxyglucose for Monitoring Primary Chemotherapy in Breast Cancer
Top Cited Papers
- 8 April 2000
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 18 (8) , 1689-1695
- https://doi.org/10.1200/jco.2000.18.8.1689
Abstract
PURPOSE: To address the role of positron emission tomography (PET) using [18F]fluorodeoxyglucose (FDG) to monitor primary (neoadjuvant) chemotherapy in patients with locally advanced breast cancer....Keywords
This publication has 28 references indexed in Scilit:
- Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.Journal of Clinical Oncology, 1998
- Prognostic role of clinical, pathological and biological characteristics in patients with locally advanced breast cancerBritish Journal of Cancer, 1998
- Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18.Journal of Clinical Oncology, 1997
- Clinical and pathological response to primary chemotherapy in operable breast cancerEuropean Journal Of Cancer, 1997
- Primary breast cancer: mammographic changes after neoadjuvant chemotherapy, with pathologic correlation.Radiology, 1996
- Locally advanced breast carcinoma: accuracy of mammography versus clinical examination in the prediction of residual disease after chemotherapy.Radiology, 1996
- Primary chemotherapy in surgically resectable breast cancerCA: A Cancer Journal for Clinicians, 1995
- Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: Preliminary results of a randomised trial: S6European Journal Of Cancer, 1994
- Treatment results, survival and prognostic factors in 109 inflammatory breast cancers: Univariate and multivariate analysisEuropean Journal Of Cancer, 1993
- Effects of primary chemotherapy in conservative treatment of breast cancer patients with operable tumors larger than 3 cmAnnals of Oncology, 1991